VulnerabilityModified
CVE-2023-40153
The affected product is vulnerable to a cross-site scripting vulnerability, which could allow an attacker to access the web application to introduce arbitrary Java Script by injecting an XSS payload into the 'hostname' parameter of the vulnerable…
MEDIUM 6.1EPSS 0.30%
Does this matter?
Lower severity and a low EPSS score (0.30%). Track it; it rarely justifies an emergency change on its own.
Description
The affected product is vulnerable to a cross-site scripting vulnerability, which could allow an attacker to access the web application to introduce arbitrary Java Script by injecting an XSS payload into the 'hostname' parameter of the vulnerable software.
- CVSS 3.1
- 6.1 MEDIUMCVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
- EPSS
- 0.30% probability · 22th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-79
- Affected
- dexma/dexgate
- Source
- ics-cert@hq.dhs.gov
References
- https://www.cisa.gov/news-events/ics-advisories/icsa-23-271-02Third Party Advisory, US Government Resource
- https://www.cisa.gov/news-events/ics-advisories/icsa-23-271-02Third Party Advisory, US Government Resource
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.